Cannabis Sativa Inc
Dogecoin Cash, Inc., through its subsidiaries, provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. It also develops Lozenges for relief; Recover, a d… Read more
Cannabis Sativa Inc (CBDS) - Net Assets
Latest net assets as of June 2025: $4.32K USD
Based on the latest financial reports, Cannabis Sativa Inc (CBDS) has net assets worth $4.32K USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.08 Million) and total liabilities ($2.07 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.32K |
| % of Total Assets | 0.21% |
| Annual Growth Rate | N/A |
| 5-Year Change | -107.87% |
| 10-Year Change | -104.48% |
| Growth Volatility | 68.98 |
Cannabis Sativa Inc - Net Assets Trend (2013–2024)
This chart illustrates how Cannabis Sativa Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cannabis Sativa Inc (2013–2024)
The table below shows the annual net assets of Cannabis Sativa Inc from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-128.87K | -117.02% |
| 2023-12-31 | $757.39K | -54.72% |
| 2022-12-31 | $1.67 Million | +60.08% |
| 2021-12-31 | $1.04 Million | -36.22% |
| 2020-12-31 | $1.64 Million | +41.13% |
| 2019-12-31 | $1.16 Million | -64.87% |
| 2018-12-31 | $3.30 Million | -46.83% |
| 2017-12-31 | $6.21 Million | +119.34% |
| 2016-12-31 | $2.83 Million | -1.59% |
| 2015-12-31 | $2.88 Million | +1129.53% |
| 2014-12-31 | $-279.62K | +99.14% |
| 2013-12-31 | $-32.50 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cannabis Sativa Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 357.5% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $82.38 Million | % |
| Total Equity | $-1.44 Million | 100.00% |
Cannabis Sativa Inc Competitors by Market Cap
The table below lists competitors of Cannabis Sativa Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Artelo Biosciences Inc
NASDAQ:ARTL
|
$3.51 Million |
|
MK Trend Co. Ltd.
KO:069640
|
$3.51 Million |
|
ODIGMA CONSULTANCY SOLUTIONS LTD
NSE:ODIGMA
|
$3.52 Million |
|
Arshiya Limited
NSE:ARSHIYA
|
$3.52 Million |
|
Kakatiya Cement Sugar & Industries Limited
NSE:KAKATCEM
|
$3.51 Million |
|
Great Atlantic Resources Corp
V:GR
|
$3.51 Million |
|
Complii Fintech Solutions Ltd
AU:CF1
|
$3.51 Million |
|
Society Pass Inc
NASDAQ:SOPA
|
$3.51 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cannabis Sativa Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -602,481 to -1,438,844, a change of -836,363.
- Net loss of 1,730,340 reduced equity.
- Other factors increased equity by 893,977.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.73 Million | -120.26% |
| Other Changes | $893.98K | +62.13% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Cannabis Sativa Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | $-4.15 | $0.04 | x |
| 2014-12-31 | $-0.02 | $0.04 | x |
| 2015-12-31 | $0.17 | $0.04 | x |
| 2017-12-31 | $0.20 | $0.04 | x |
| 2018-12-31 | $0.10 | $0.04 | x |
| 2019-12-31 | $0.00 | $0.04 | x |
| 2020-12-31 | $0.02 | $0.04 | x |
| 2021-12-31 | $-0.01 | $0.04 | x |
| 2022-12-31 | $0.01 | $0.04 | x |
| 2023-12-31 | $-0.01 | $0.04 | x |
| 2024-12-31 | $-0.01 | $0.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cannabis Sativa Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -215.56%
- • Asset Turnover: 0.47x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-16912.36%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 0.00% | -200947.17% | 0.00x | 0.00x | $-14.34 Million |
| 2015 | -256.41% | -63558.29% | 0.00x | 1.13x | $-7.67 Million |
| 2016 | -119.87% | -10742.51% | 0.01x | 1.42x | $-3.39 Million |
| 2017 | -179.99% | -2378.75% | 0.04x | 1.84x | $-7.98 Million |
| 2018 | -198.97% | -816.35% | 0.10x | 2.35x | $-4.34 Million |
| 2019 | -184633.49% | -339.42% | 0.39x | 1398.46x | $-3.94 Million |
| 2020 | -329.16% | -106.78% | 0.63x | 4.87x | $-2.24 Million |
| 2021 | 0.00% | -132.91% | 0.72x | 0.00x | $-2.42 Million |
| 2022 | -318.05% | -77.97% | 0.61x | 6.73x | $-1.25 Million |
| 2023 | 0.00% | -118.61% | 0.58x | 0.00x | $-1.33 Million |
| 2024 | 0.00% | -215.56% | 0.47x | 0.00x | $-1.59 Million |
Industry Comparison
This section compares Cannabis Sativa Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $79,108,599
- Average return on equity (ROE) among peers: -247.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cannabis Sativa Inc (CBDS) | $4.32K | 0.00% | 479.68x | $3.51 Million |
| Accolade, Inc. (ACCD) | $473.79 Million | -97.02% | 0.91x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $78.70 Million | 22.11% | 1.51x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-462.52K | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.89 Million |
| Alternate Health Corp (AHGIF) | $1.07 Million | -2231.82% | 7.94x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $2.09 Million | -130.52% | 0.72x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $-198.56K | 0.00% | 0.00x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-21.78K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $247.79 Million | -38.62% | 0.31x | $78.62 Million |